Browse Category

NASDAQ:DXCM News 7 July 2025 - 13 January 2026

DexCom stock jumps in premarket after early Q4 sales and 2026 outlook; what DXCM investors watch next

DexCom stock jumps in premarket after early Q4 sales and 2026 outlook; what DXCM investors watch next

DexCom shares rose about 5% premarket Tuesday after the company reported preliminary Q4 revenue of $1.26 billion, up 13% year over year, and issued 2026 guidance above prior expectations. U.S. sales reached $892 million, with international revenue at $368 million. The company reaffirmed 2025 margin targets and raised 2026 goals. Barclays downgraded DexCom, citing competitive pressures despite strong sales.
Accenture stock jumps 4% on fresh AI moves: Profitmind deal, Faculty buy plan

Accenture stock jumps 4% on fresh AI moves: Profitmind deal, Faculty buy plan

Accenture shares climbed 4.1% to $285.18 Thursday after the company announced a new AI partnership with Profitmind and a deal to buy UK-based Faculty. The Faculty acquisition, which adds over 400 staff, aims to expand Accenture’s “safe AI” offerings. Analyst Surinder Thind raised his price target to $290. General counsel Joel Unruch sold 1,332 shares at $275 each in a prearranged trade.
Global Wearable Health Tech News – June and July 2025

Global Wearable Health Tech News – June and July 2025

Biobeat’s cuffless vital-sign patch received FDA clearance and CE marking for hospital-grade remote monitoring, enabling cuffless measurement of blood pressure, heart rate, SpO2, and respiratory rate via PPG and AI. On June 19, PharmaSens and SiBionics announced niia™ signature, an all-in-one patch that combines a continuous glucose monitor with an insulin pump, unveiled at ADA 2025. LifePlus’s LifeLeaf non-invasive monitor (June 24) is a cuffless device for continuous glucose and blood pressure tracking, validated in Mayo Clinic trials with readings within about 10.8% of glucometers and BP error around 0.03 mmHg. Wearable Devices Ltd.’s Large-Motion AI Platform expansion on June

Stock Market Today

AMD stock rebounds 8% after post-earnings slump as payrolls, CPI loom

AMD stock rebounds 8% after post-earnings slump as payrolls, CPI loom

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, rebounding after a 13% plunge earlier in the week on weak guidance and AI competition fears. The Philadelphia semiconductor index rose 5.7% as chip stocks led a broader market rally. Investors are awaiting next week’s U.S. payrolls and inflation data, which could shift rate expectations for tech.
Netflix stock price ends higher as DOJ widens review of Warner deal — what to watch next week

Netflix stock price ends higher as DOJ widens review of Warner deal — what to watch next week

7 February 2026
Netflix shares rose 1.6% to $82.20 Friday as the Justice Department expanded its antitrust review of the company’s planned $82.7 billion Warner Bros Discovery acquisition. A Wall Street Journal report said investigators are probing possible anti-competitive tactics. Director Reed Hastings reported a transfer of 241,944 shares via a family trust, according to an SEC filing.
Go toTop